Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005) [Phase 1]

View source ↗

Summary

Phase 1 study assessing interactions between MK-1942 and donepezil in participants with Alzheimer's disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil (donepezil)
  • MK-1942

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-08-15